Statement from IDSA, HIVMA, SHEA, and PIDS. The U.S. Customs and Border Patrol’s policy and practice of allowing immigrant families to be separated because a parent is living with HIV runs counter to more than three decades of science and to existing public health guidelines.
Global diagnostics firm Randox will attend the 71st AACC Annual Scientific Meeting and will showcase its unique life science capabilities in areas including Stroke differentiation and quality control for a range of infectious diseases.
A team of scientists led by Texas Biomed’s Assistant Professor Smita Kulkarni, Ph.D. and Mary Carrington, Ph.D., at the Frederick National Laboratory for Cancer Research, published results of a study that pinpointed a long noncoding RNA molecule which influences a key receptor involved in HIV infection and progression of the disease.
Researchers at the Icahn School of Medicine at Mount Sinai have developed a novel vaccine consisting of DNA and recombinant proteins⸺proteins composed of a portion of an HIV protein and another unrelated protein.
The World Health Organization’s declaration today that the year-long Ebola crisis is a Public Health Emergency of International Concern is hoped to raise much-needed awareness and resources for preparedness and control efforts across the region. The decision was made following new incidents highlighting risks of repeated cross-border spread of the ongoing Ebola outbreak in the Democratic Republic of Congo.
Even after nearly a decade of strict HIV treatment, cells sheltering the virus could be found in the cerebrospinal fluid of half of participants in a national clinical trial of people living with HIV. Moreover, those participants had higher likelihood of cognitive deficits.
A discovery about HIV published in Nature Immunology paves the way to new therapies that might complement antiretroviral therapy.
Rutgers researchers find patients who perceive their primary care providers as lacking empathy and not willing to include them in decision making are at risk for abandoning treatment or not seeking treatment at all
Taigen Bioscience Corporation welcomes you to booth 864 to see the sample-to-resultDNA/RNA testing automation by LabTurbo SP-qPCR AIO System
Women living with HIV are less likely than men to achieve viral suppression with antiretroviral therapy. Reduction in alcohol use is a possible strategy to improve health outcomes in women with HIV, with evidence that unhealthy alcohol use (>7 drinks per week or >4 drinks per occasion for women) is associated with poorer adherence to treatment, lower rates of viral suppression, and faster disease progression. Several medications are available on prescription to help reduce drinking, including naltrexone, which is taken as a once-daily pill; however, none have been studied in relation to clinical outcomes in people with HIV. Researchers from universities in Florida have conducted a clinical trial, published in the journal Alcoholism: Clinical & Experimental Research , to understand the effect of naltrexone on drinking behavior and clinical outcomes in women with HIV who engage in unhealthy alcohol use, exceeding recommended drinking levels.
Chris Beyrer, MD, MPH, a longtime faculty member at the Johns Hopkins Bloomberg School of Public Health, globally recognized AIDS researcher and advocate, and former president of the International AIDS Society (IAS), is among five finalists to lead the Joint United Nations Programme on HIV/AIDS.
For the first time researchers have been able to completely eliminate HIV from a mouse model. It marks a critical step toward the development of a possible cure for human HIV infection.
Below are summaries of recent Fred Hutch research, with links for additional background and media contacts.
When people suffer from both HIV and TB, it creates “one of the biggest health problems in the world,” according to Texas Biomed Assistant Professor Smita Kulkarni, Ph.D. Now, the National Institutes of Health is funding a two-year study by Texas Biomed scientists developing a lab model that mimics the early stages of the co-infection of these two diseases.
Northeast Ohio philanthropist Roe Green has added $9 million to her original gift of $5 million from 2014 to the travel medicine and global health center named for her at University Hospitals based in Cleveland.
Scientists have taken a common, yet laborious lab test and redesigned it to be performed in small 3D printed pipette tips used to measure and transfer fluids in the laboratory.
HIV testing is expensive ($50 to $200 per test), technically complex, and requires trained technicians. Researchers are developing a rapid, disposable, automated, and low-cost HIV viral load assay to increase timely access to HIV care and to improve treatment outcomes. The technology is highly sensitive, inexpensive (less than $1), and quick (results in 45 minutes or less). Moreover, the technology is highly stable, and doesn’t require refrigeration or a regular electric supply to enable HIV viral load at point-of-care settings.
New testing methods being developed by Molecular Testing Labs and Boise State University utilize RNA molecular signatures, which can be detected using cutting edge technology and lab techniques. This means that people at risk for contracting HIV can get tested much earlier than current methods – typically within the same week as the potential exposure.
Nurse practitioners are more likely to conduct HIV screenings if they feel that their colleagues support routine screenings, according to new research from Binghamton University, State University of New York. This comes in advance of National HIV Testing Day, taking place June 27.
Perry N. Halkitis, the author Out in Time: From Stonewall to Queer, How Gay Men Came of Age Across the Generations, addresses how Stonewall and the AIDS crisis have brought awareness and changes the ways the medical profession addresses health care of LGBTQ people.
Duke researchers describe a previously unidentified route for antibodies to be transferred from the mother to the fetus, illuminating a potential way to capitalize on this process to control when and how certain antibodies are shared.
The National Institutes of Health (NIH) has awarded a seven-year, $23 million grant to researchers at Albert Einstein College of Medicine and Montefiore Health System to study HIV and the chronic illnesses that often accompany HIV infection, including cardiovascular and lung disease, diabetes, and cancer.
Sanjay B. Maggirwar, PhD, MBA, has been selected to serve as chair of the Department of Microbiology, Immunology, and Tropical Medicine at the George Washington University School of Medicine and Health Sciences
The Department of Health and Human Services’ announcement Wednesday that it will halt funding for research involving the use of human fetal tissue conducted within the National Institutes of Health
Every day, there are more than 1 million new cases of curable sexually transmitted infections (STIs) among people aged 15-49 years, according to data released today by the World Health Organization.
The results of a study led by physicians at Fred Hutchinson Cancer Research Center showed that patients living with HIV and one of a variety of potentially deadly cancers could be safely treated with the immunotherapy drug pembrolizumab, also known by its brand name, KEYTRUDA®.
Scientists at Fred Hutchinson Cancer Research Center took a step toward making gene therapy more practical by simplifying the way gene-editing instructions are delivered to cells. Using a gold nanoparticle instead of an inactivated virus, they safely delivered gene-editing tools in lab models of HIV and inherited blood disorders, as reported May 27 in Nature Materials.
Allowing Discrimination, Administration Proposals Threaten Transgender Health and Progress Against HIV Epidemic
According to scientists who study women infected with HIV, statistics often paint an impressionist view of the lives of these women that misses the granular detail that tells the real story. The imprecise big picture is that most of this population is doing a good job at suppressing the virus, but facts gathered on the ground show that many struggle with issues of daily living that can make taking a pill to keep HIV at bay difficult.
A new HIV vaccine delivery strategy appears to enhance the protective immune response in a preclinical model. Scientists at the La Jolla Institute for Immunology (LJI) have discovered that delivering an HIV vaccine in small doses over a series of days leads to a stronger immune response than when the same vaccine is given all at once.
HHS’s “Conscience Rights” Rule Threatens Public Health
In honor of National Women’s Health Week, the REACH Program (Respectful and Equitable Access to Comprehensive Healthcare) at Mount Sinai is hosting a Women’s Health Fair for the Harlem and surrounding communities.
Children with HIV are much more susceptible to TB and also much more likely to die from it. This grant will fund international research to investigate why, both in the lab and in the field.
University at Buffalo researchers interviewed a small sample of PrEP-prescribing providers in New York State to conduct a qualitative analysis of their perspectives on the preventive medication.
Georgetown University Medical Center (GUMC) announces the appointment of Deus Bazira, DrPH, MPH, MBA, BPharm, an expert in health systems strengthening and a public health practitioner with decades of in-depth field level practical experience in global health in emerging economies, to establish and co-direct Georgetown’s new Center for Global Health Practice and Impact (CGHPI).
Researchers have used a molecular “can opener” and advanced imaging to expose parts of the HIV envelope and reveal in detail a previously unknown virus shape with unique vulnerabilities that can be targeted by antibodies. This could open new directions for vaccine development.
Timed vaginal insemination is a safe, effective way to help HIV-affected couples conceive, finds a new pilot study in Kenya led by a Michigan Medicine researcher.
Scientists from Sanford Burnham Prebys and the Genomics Institute of the Novartis Research Foundation have revealed an open-access, web-based portal that integrates more than 40 advanced bioinformatics data sources to allow non-technical users to generate insights in one click. Called Metascape, this tool removes data analysis barriers—allowing researchers to spend more time on important biological questions and less time building and troubleshooting a data analysis workflow. The platform was described today in Nature Communications.
Southern Research announced today that April M. Brys, Ph.D., an experienced life sciences executive with a strong track record in research and leadership roles, has been named vice president of the non-profit organization’s Drug Development division.
In a first on the quest to cure HIV, University of Pittsburgh scientists report that they’ve developed an all-in-one immunotherapy approach that not only kicks HIV out of hiding in the immune system, but also kills it. The key lies in immune cells designed to recognize an entirely different virus.
The rate of human papillomavirus (HPV) infection is high among young minority gay, bisexual, and other men who have sex with men despite the availability of a vaccine that can prevent the infection, a Rutgers School of Public Health study found.
University of Utah S.J. Quinney College of Law Professor Clifford Rosky among parties to file lawsuit against State of Arizona challenging anti-gay curriculum laws
The human immunodeficiency virus (HIV) is no longer a death sentence, yet a cure remains elusive. While current therapies can successfully manage active infection, the virus can survive in tissue reservoirs – including macrophage cells, which play an important role in the immune system.
For the first time, a person living with HIV has donated a kidney to a transplant recipient also living with HIV. A multidisciplinary team from Johns Hopkins Medicine completed the living donor HIV-to-HIV kidney transplant on Mar. 25. The doctors say both the donor and the recipient are doing well.
Privacy concerns linked to both health facilities and providers are major barriers to increasing the number of men who are tested and treated for HIV in Cote d’Ivoire, suggests new Johns Hopkins Center for Communication Programs (CCP) research. CCP is based at the Johns Hopkins Bloomberg School of Public Health.
Teens and young adults who were exposed to HIV and antiretroviral therapy before birth but are HIV-negative themselves are at increased risk of obesity and asthma-like symptoms, according to research to be presented Saturday, March 23 at ENDO 2019, the Endocrine Society’s annual meeting in New Orleans, La.
There have been significant advances in clinical and scientific research in the understanding of blood-borne pathogens (BBPs), which are pathogenic microorganisms that are present in human blood and can cause disease in humans. These pathogens include, but are not limited to, hepatitis C virus (HCV), hepatitis D virus (HDV) and human immunodeficiency virus (HIV). Updating a statement from 1995, this document is intended as a general guide to clinical practice based on the current state of evidence, while acknowledging the need for modification as new knowledge becomes available.
A new study, published this month in Lancet HIV by Penn Medicine researchers, shows that a naltrexone implant placed under the skin was more effective at helping HIV-positive patients with an opioid addiction reduce relapse and have better HIV-related outcomes compared to the oral drug.
Shield Diagnostics, an Andreessen Horowitz-backed clinical laboratory tackling antibiotic resistance by bringing precision medicine to infectious disease, announced the launch of Target-NG, a rapid molecular test for antibiotic susceptibility in Neisseria gonorrhoeae.
The National Institute of Allergy and Infectious Diseases awarded a grant to researchers at New York University College of Dentistry to study HIV latency. The grant provides nearly $2 million over five years to support research led by David N. Levy, PhD, associate professor of basic science and craniofacial biology at NYU Dentistry.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right